Genetic testing for susceptibility to breast and ovarian cancer: Evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices
Melanie F. Myers(Cincinnati Children's Hospital Medical Center), Linda Bradley(University of Gothenburg), W. Andrew Faucett(Geisinger Medical Center), William C. Whitworth(Centers for Disease Control and Prevention), James A. Litch(Centers for Disease Control and Prevention), Man‐Huei Chang(Centers for Disease Control and Prevention), Debra E. Irwin(University of North Carolina at Chapel Hill), Judy Mouchawar(University of Colorado Denver), Lori Armstrong(Centers for Disease Control and Prevention), Kassim Sidibé(Centers for Disease Control and Prevention), Cynthia Jorgensen(Centers for Disease Control and Prevention), Barbara A. Bernhardt(University of Houston)
Cited by 77
Related Papers
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
|Genetics in Medicine|2013|741
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
|Genetics in Medicine|2007|693
Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
|The American Journal of Human Genetics|2014|378
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
|American Journal of Epidemiology|2002|372
Differences in the Patterns of Health Care System Distrust Between Blacks and Whites
|Journal of General Internal Medicine|2008|291